David Rolfe Johnson & Johnson Transaction History

Wedgewood Partners Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $4,630 - $4,983	30 Added 0.62%	4,905 $811,000
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $113,287 - $135,195	-750 Reduced 13.33%	4,875 $755,000
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $124,154 - $139,337	-775 Reduced 12.11%	5,625 $993,000
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $8,066 - $8,976	-50 Reduced 0.78%	6,400 $1.05 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $114,651 - $130,202	725 Added 12.66%	6,450 $1.14 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $62,372 - $69,204	-400 Reduced 6.53%	5,725 $979,000
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $161 - $179	-1 Reduced 0.02%	6,125 $989,000
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $27,749 - $29,766	-174 Reduced 2.76%	6,126 $1.01 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $30,395 - $35,720	250 Added 4.13%	6,300 $870,000
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $59,700 - $65,880	500 Added 9.01%	6,050 $734,000
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $26,244 - $28,724	-200 Reduced 3.48%	5,550 $775,000
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $744,452 - $778,435	5,750	5,750 $747,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Wedgewood Partners Inc, based on Form 13F filings with the SEC.

Stay updated on Wedgewood Partners Inc and David Rolfe with notifications on news.